Effectiveness of MedCem MTA® in Pulpotomies Primary Teeth, Pulpotomies Primary Teeth
Conditions
Keywords
pulpotomy, MTA, primary teeth, formocresol
Brief summary
assess the effect of MedCem MTA as a pulp medicament following pulpotomy in human primary molars with carious pulp exposure in comparison to Formocresol.
Interventions
PROCEDUREMedCem MTA pulpotomies in primary teeth.
Sponsors
Hadassah Medical Organization
Study design
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
2 Years to 10 Years
Healthy volunteers
Yes
Inclusion criteria
1. healthy children 2. with Asymptomatic primary molars with a deep carious lesion; 3. Exposure of a vital pulp by caries; 4. No clinical or radiographic evidence of pulp degeneration, such as excessive bleeding from the root canal, internal root resorption, inter-radicular and/or periapical bone destruction,swelling, or sinus tract; 5. Ability to perform a leakage free restoration of the teeth using stainless steel crown, or amalgam/resin based restoration.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Success of MedCem MTA pulpotomy in primary molar | Up to 36 months | No pain, no swelling or sinus tract, no internal root resorption progressing into the bone, no furcation and/or periapical bond destruction. |
Countries
Israel
Outcome results
None listed